Trade alert for break above Point of Control (redline)
Earnings highlights
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases.
Q4 GAAP EPS of -$0.08 in-line.
Revenue of $1.22M (-1.6% Y/Y) beats by $0.29M.
Earnings highlights
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases.
Q4 GAAP EPS of -$0.08 in-line.
Revenue of $1.22M (-1.6% Y/Y) beats by $0.29M.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.